Alignment Healthcare (NASDAQ:ALHC) President Sells $626,100.00 in Stock
by Scott Moore · The Cerbat GemAlignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $20.87, for a total transaction of $626,100.00. Following the completion of the transaction, the president directly owned 1,028,813 shares of the company’s stock, valued at $21,471,327.31. This represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Dawn Christine Maroney also recently made the following trade(s):
- On Wednesday, March 18th, Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16.
- On Monday, March 16th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.48, for a total transaction of $524,400.00.
- On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.45, for a total transaction of $508,021.85.
- On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.63, for a total transaction of $618,900.00.
- On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $22.48, for a total transaction of $674,400.00.
Alignment Healthcare Price Performance
Shares of Alignment Healthcare stock traded down $0.36 during trading on Wednesday, hitting $20.92. 1,370,751 shares of the company’s stock traded hands, compared to its average volume of 3,456,949. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The company has a market cap of $4.27 billion, a PE ratio of -2,089.91, a PEG ratio of 3.11 and a beta of 1.20. The firm’s fifty day moving average price is $19.22 and its 200 day moving average price is $19.11. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.71.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last posted its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. Alignment Healthcare’s revenue for the quarter was up 44.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.16) earnings per share. Analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.
Institutional Trading of Alignment Healthcare
A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its stake in shares of Alignment Healthcare by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock valued at $305,983,000 after acquiring an additional 1,524,218 shares during the period. Wellington Management Group LLP boosted its position in shares of Alignment Healthcare by 26.9% during the 4th quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock valued at $277,900,000 after acquiring an additional 2,981,166 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its position in shares of Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after acquiring an additional 79,268 shares during the last quarter. Invesco Ltd. boosted its position in shares of Alignment Healthcare by 38.9% during the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after acquiring an additional 1,735,962 shares during the last quarter. Finally, 8 Knots Management LLC raised its holdings in Alignment Healthcare by 6.4% during the 2nd quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after buying an additional 300,409 shares during the period. Hedge funds and other institutional investors own 86.19% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. KeyCorp restated an “overweight” rating and issued a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research report on Friday, January 30th. TD Cowen raised their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday, January 16th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, March 7th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.75.
Get Our Latest Report on Alignment Healthcare
Alignment Healthcare Company Profile
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.